Tessera Raises $230M to Develop ‘Gene Writing’ into Novel Genetic Therapy
Tessera Therapeutics, a Boston-based life science startup raised $230M in Series B financing. Incubated at Flagship Labs since 2018, Tessera debuted in 2020 with a $50M investment to innovate …
Read More